VRCA logo

Verrica Pharmaceuticals (VRCA) Company Overview

Profile

Full Name:

Verrica Pharmaceuticals Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 15, 2018

Indexes:

Not included

Description:

Verrica Pharmaceuticals focuses on developing and commercializing innovative treatments for skin conditions, particularly for warts. Their lead product, VP-102, is a topical therapy designed to target common skin issues, aiming to improve patients' quality of life through effective and convenient solutions.

Key Details

Price

$0.63

Annual Revenue

$5.12 M(-43.27% YoY)

Annual EPS

-$1.48(-105.56% YoY)

Annual ROE

-224.08%

Beta

1.31

Events Calendar

Earnings

Next earnings date:

May 13, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 20, 24 Needham
Hold
Nov 6, 24 HC Wainwright & Co.
Neutral
Nov 5, 24 RBC Capital
Sector Perform
Nov 5, 24 Needham
Hold
Oct 21, 24 TD Cowen
Buy
Oct 4, 24 RBC Capital
Outperform
Oct 3, 24 Needham
Hold
Oct 2, 24 Brookline Capital
Hold
Aug 15, 24 RBC Capital
Outperform
Aug 15, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Verrica Pharmaceuticals?
  • Does Verrica Pharmaceuticals pay dividends?
  • What sector is Verrica Pharmaceuticals in?
  • What industry is Verrica Pharmaceuticals in?
  • What country is Verrica Pharmaceuticals based in?
  • When did Verrica Pharmaceuticals go public?
  • Is Verrica Pharmaceuticals in the S&P 500?
  • Is Verrica Pharmaceuticals in the NASDAQ 100?
  • Is Verrica Pharmaceuticals in the Dow Jones?
  • When was Verrica Pharmaceuticals's last earnings report?
  • When does Verrica Pharmaceuticals report earnings?
  • Should I buy Verrica Pharmaceuticals stock now?

What is the ticker symbol for Verrica Pharmaceuticals?

The ticker symbol for Verrica Pharmaceuticals is NASDAQ:VRCA

Does Verrica Pharmaceuticals pay dividends?

No, Verrica Pharmaceuticals does not pay dividends

What sector is Verrica Pharmaceuticals in?

Verrica Pharmaceuticals is in the Healthcare sector

What industry is Verrica Pharmaceuticals in?

Verrica Pharmaceuticals is in the Biotechnology industry

What country is Verrica Pharmaceuticals based in?

Verrica Pharmaceuticals is headquartered in United States

When did Verrica Pharmaceuticals go public?

Verrica Pharmaceuticals's initial public offering (IPO) was on June 15, 2018

Is Verrica Pharmaceuticals in the S&P 500?

No, Verrica Pharmaceuticals is not included in the S&P 500 index

Is Verrica Pharmaceuticals in the NASDAQ 100?

No, Verrica Pharmaceuticals is not included in the NASDAQ 100 index

Is Verrica Pharmaceuticals in the Dow Jones?

No, Verrica Pharmaceuticals is not included in the Dow Jones index

When was Verrica Pharmaceuticals's last earnings report?

Verrica Pharmaceuticals's most recent earnings report was on Nov 4, 2024

When does Verrica Pharmaceuticals report earnings?

The next expected earnings date for Verrica Pharmaceuticals is May 13, 2025

Should I buy Verrica Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions